BRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1BB

BRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1

24,500.000ARSD
−700.000−2.78%
At close at 22:11 GMT
ARS
No trades
See on Supercharts

BMY fundamentals

BRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 revenue breakdown overview

The greatest contribution to the revenue figure was made by United States — last year it brought BRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 31.23 T ARS, and the year before that — 9.29 T ARS.

By source
2017
2018
2019
2020
2021
2022
2023
2024
‪0.00‬
‪‪12.00 T‬‬
‪‪24.00 T‬‬
‪‪36.00 T‬‬
‪‪48.00 T‬‬
Innovative Medicines
Currency: ARS
2017
2018
2019
2020
2021
2022
2023
2024
Innovative Medicines
‪‪3.01 T‬‬
‪‪4.42 T‬‬
‪‪6.04 T‬‬
‪‪13.25 T‬‬
‪‪44.23 T‬‬
By country
2017
2018
2019
2020
2021
2022
2023
2024
‪0.00‬
‪‪12.00 T‬‬
‪‪24.00 T‬‬
‪‪36.00 T‬‬
‪‪48.00 T‬‬
United States
International
Global
Europe
Japan
Currency: ARS
2017
2018
2019
2020
2021
2022
2023
2024
United States
‪‪1.88 T‬‬
‪‪2.78 T‬‬
‪‪4.16 T‬‬
‪‪9.29 T‬‬
‪‪31.23 T‬‬
International
‪‪385.73 B‬‬
‪‪536.24 B‬‬
‪‪1.76 T‬‬
‪‪3.75 T‬‬
‪‪12.09 T‬‬
Global
‪‪44.60 B‬‬
‪‪81.12 B‬‬
‪‪109.06 B‬‬
‪‪205.81 B‬‬
‪‪912.01 B‬‬
Europe
‪‪696.46 B‬‬
‪‪1.02 T‬‬
Japan